MiR-107 function as a tumor suppressor gene in colorectal cancer by targeting transferrin receptor 1

被引:65
作者
Fu, Yuxiang [1 ]
Lin, Liewen [1 ]
Xia, Ligang [1 ]
机构
[1] South Univ Sci & Technol, Jinan Univ, Dept Gastrointestinal Surg, Shenzhen Peoples Hosp,Clin Med Coll 2,Affiliated, Shenzhen 518055, Peoples R China
关键词
Colorectal cancer; microRNA107 (miR-107); Cancer progress; Transferrin receptor 1 (TFR1); COLON-CANCER; CELLS; MICRORNA; PROGRESSION; EXPRESSION; THERAPY; MIR-34A; MIRNAS; TISSUE; SERUM;
D O I
10.1186/s11658-019-0155-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
BackgroundWhile microRNAs (miRNAs) are known to play a critical role in the progression of colorectal cancer, the role of miR-107 remains unknown. We evaluated its role and explored the underlying mechanism.Materials & methodsMTT, wound-healing, transwell migration and transwell invasion assays were performed to evaluate the role of miR-107 in SW629 cell proliferation, migration and invasion. Real time-PCR and dual-luciferase reporter gene, TFR1 overexpression and western blotting assays were used to explore the underlying mechanism.ResultsMiR-107 is downregulated in colorectal cancer tissues and several human colorectal cancer cell lines. Low miR-107 expression often indicates a poor survival rate for colorectal cancer patients. MiR-107 suppresses the proliferation, migration and invasion of SW620 cells by negatively regulating transferrin receptor 1 (TFR1).ConclusionMiR-107 suppresses the metastasis of colorectal cancer and could be a potential therapy target in colorectal cancer patients.
引用
收藏
页数:11
相关论文
共 36 条
[1]
The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas [J].
Adams, Brian D. ;
Parsons, Christine ;
Slack, Frank J. .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2016, 20 (06) :737-753
[2]
Combinatorial nanomedicines for colon cancer therapy [J].
Anitha, A. ;
Maya, S. ;
Sivaram, Amal J. ;
Mony, U. ;
Jayakumar, R. .
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2016, 8 (01) :151-159
[3]
Current treatment options for colon cancer peritoneal carcinomatosis [J].
Aoyagi, Tomoyoshi ;
Terracina, Krista P. ;
Raza, Ali ;
Takabe, Kazuaki .
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (35) :12493-12500
[4]
Increased levels of serum and tissue miR-107 in human gastric cancer: Correlation with tumor hypoxia [J].
Ayremlou, Nooshin ;
Mozdarani, Hossein ;
Mowla, Seyed Javad ;
Delavari, Alireza .
CANCER BIOMARKERS, 2015, 15 (06) :851-860
[5]
Diagnostic, prognostic, and therapeutic potency of microRNA 21 in the pathogenesis of colon cancer, current status and prospective [J].
Bahreyni, Amirhossein ;
Rezaei, Melika ;
Bahrami, Afsane ;
Khazaei, Majid ;
Fiuji, Hamid ;
Ryzhikov, Mikhail ;
Ferns, Gordon A. ;
Avan, Amir ;
Hassanian, Seyed Mahdi .
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (06) :8075-8081
[6]
MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[7]
Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors [J].
Beg, Muhammad S. ;
Brenner, Andrew J. ;
Sachdev, Jasgit ;
Borad, Mitesh ;
Kang, Yoon-Koo ;
Stoudemire, Jay ;
Smith, Susan ;
Bader, Andreas G. ;
Kim, Sinil ;
Hong, David S. .
INVESTIGATIONAL NEW DRUGS, 2017, 35 (02) :180-188
[8]
Colon Cancer, Version 1.2017 Clinical Practice Guidelines in Oncology [J].
Benson, Al B., III ;
Venook, Alan P. ;
Cederquist, Lynette ;
Chan, Emily ;
Chen, Yi-Jen ;
Cooper, Harry S. ;
Deming, Dustin ;
Engstrom, Paul F. ;
Enzinger, Peter C. ;
Fichera, Alessandro ;
Grem, Jean L. ;
Grothey, Axel ;
Hochster, Howard S. ;
Hoffe, Sarah ;
Hunt, Steven ;
Kamel, Ahmed ;
Kirilcuk, Natalie ;
Krishnamurthi, Smitha ;
Messersmith, Wells A. ;
Mulcahy, Mary F. ;
Murphy, James D. ;
Nurkin, Steven ;
Saltz, Leonard ;
Sharma, Sunil ;
Shibata, David ;
Skibber, John M. ;
Sofocleous, Constantinos T. ;
Stoffel, Elena M. ;
Stotsky-Himelfarb, Eden ;
Willett, Christopher G. ;
Wu, Christina S. ;
Gregory, Kristina M. ;
Freedman-Cass, Deborah .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (03) :370-398
[9]
miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans [J].
Chen, Pai-Sheng ;
Su, Jen-Liang ;
Cha, Shih-Ting ;
Tarn, Woan-Yuh ;
Wang, Ming-Yang ;
Hsu, Hsing-Chih ;
Lin, Ming-Tsan ;
Chu, Chia-Yu ;
Hua, Kuo-Tai ;
Chen, Chiung-Nien ;
Kuo, Tsang-Chih ;
Chang, King-Jen ;
Hsiao, Michael ;
Chang, Yi-Wen ;
Chen, Jin-Shing ;
Yang, Pan-Chyr ;
Kuo, Min-Liang .
JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (09) :3442-3455
[10]
The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer [J].
Daniels, Tracy R. ;
Delgado, Tracie ;
Rodriguez, Jose A. ;
Helguera, Gustavo ;
Penichet, Manuel L. .
CLINICAL IMMUNOLOGY, 2006, 121 (02) :144-158